🇺🇸 FDA
Patent

US 9255085

Carboxamide compounds and methods for using the same

granted A61KA61K31/437A61K31/454

Quick answer

US patent 9255085 (Carboxamide compounds and methods for using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K31/437, A61K31/454, A61K31/4545, A61K31/4725